Lu RM - Search Results

1

Current landscape of mRNA technologies and delivery systems for new modality therapeutics.

Lu RM, Hsu HE, Perez SJLP, Kumari M, Chen GH, Hong MH, Lin YS, Liu CH, Ko SH, Concio CAP, Su YJ, Chang YH, Li WS, Wu HC. Lu RM, et al. J Biomed Sci. 2024 Sep 10;31(1):89. doi: 10.1186/s12929-024-01080-z. J Biomed Sci. 2024. PMID: 39256822 Free PMC article. Review.

2

Advancement and applications of peptide phage display technology in biomedical science.

Wu CH, Liu IJ, Lu RM, Wu HC. Wu CH, et al. Among authors: lu rm. J Biomed Sci. 2016 Jan 19;23:8. doi: 10.1186/s12929-016-0223-x. J Biomed Sci. 2016. PMID: 26786672 Free PMC article.

3

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection.

Hwang YC, Lu RM, Su SC, Chiang PY, Ko SH, Ke FY, Liang KH, Hsieh TY, Wu HC. Hwang YC, et al. Among authors: lu rm. J Biomed Sci. 2022 Jan 4;29(1):1. doi: 10.1186/s12929-021-00784-w. J Biomed Sci. 2022. PMID: 34983527 Free PMC article. Review.

4

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.

Kumari M, Lu RM, Li MC, Huang JL, Hsu FF, Ko SH, Ke FY, Su SC, Liang KH, Yuan JP, Chiang HL, Sun CP, Lee IJ, Li WS, Hsieh HP, Tao MH, Wu HC. Kumari M, et al. Among authors: lu rm. J Biomed Sci. 2022 Sep 12;29(1):68. doi: 10.1186/s12929-022-00852-9. J Biomed Sci. 2022. PMID: 36096815 Free PMC article. Review.

5

Development of therapeutic antibodies for the treatment of diseases.

Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Lu RM, et al. J Biomed Sci. 2020 Jan 2;27(1):1. doi: 10.1186/s12929-019-0592-z. J Biomed Sci. 2020. PMID: 31894001 Free PMC article. Review.

6

Antibody cocktail effective against variants of SARS-CoV-2.

Liang KH, Chiang PY, Ko SH, Chou YC, Lu RM, Lin HT, Chen WY, Lin YL, Tao MH, Jan JT, Wu HC. Liang KH, et al. Among authors: lu rm. J Biomed Sci. 2021 Nov 23;28(1):80. doi: 10.1186/s12929-021-00777-9. J Biomed Sci. 2021. PMID: 34814920 Free PMC article.

7

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.

Chiang HL, Liang KH, Lu RM, Kuo TW, Lin YL, Wu HC. Chiang HL, et al. Among authors: lu rm. J Biomed Sci. 2023 Jul 31;30(1):59. doi: 10.1186/s12929-023-00955-x. J Biomed Sci. 2023. PMID: 37525188 Free PMC article.

8

Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.

Lu RM, Chang YL, Chen MS, Wu HC. Lu RM, et al. Biomaterials. 2011 Apr;32(12):3265-74. doi: 10.1016/j.biomaterials.2010.12.061. Biomaterials. 2011. PMID: 21306768

9

Targeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imaging.

Lu RM, Chen MS, Chang DK, Chiu CY, Lin WC, Yan SL, Wang YP, Kuo YS, Yeh CY, Lo A, Wu HC. Lu RM, et al. PLoS One. 2013 Jun 11;8(6):e66128. doi: 10.1371/journal.pone.0066128. Print 2013. PLoS One. 2013. PMID: 23776619 Free PMC article.

10

Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models.

Chang DK, Li PC, Lu RM, Jane WN, Wu HC. Chang DK, et al. Among authors: lu rm. PLoS One. 2013 Dec 27;8(12):e83239. doi: 10.1371/journal.pone.0083239. eCollection 2013. PLoS One. 2013. PMID: 24386166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters